High resistance implanted bronchial isolation devices and methods

Inventors

Radhakrishnan, Sri • Olivera, Ryan

Assignees

Pulmonx Corp

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11529224-B2

Patent

Publication Date

2022-12-20

Expiration Date


Abstract

Disclosed are methods and devices for regulating fluid flow to and from a region of a patient's lung, such as to achieve a desired fluid flow dynamic to a lung region during respiration and/or to induce collapse in one or more lung regions. Pursuant to an exemplary procedure, an identified region of the lung is targeted for treatment. The targeted lung region is then bronchially isolated to regulate airflow into and/or out of the targeted lung region through one or more bronchial passageways that feed air to the targeted lung region. An exemplary flow control device is configured to block fluid flow in the inspiratory direction and the expiratory direction at normal breathing pressures and allow fluid flow in the expiratory direction at higher than normal breathing pressures.

Core Innovation

The invention provides an implantable bronchial flow control device suitable for placement in a bronchial passageway to isolate targeted lung regions and regulate airflow to promote regional lung collapse. The device includes a valve configured to block airflow in the inspiratory direction while permitting airflow in the expiratory direction. The valve remains closed during periods of no airflow and during normal breathing pressures, but opens for expiratory airflow at coughing pressures.

The claimed device configurations employ either a first and second lip arrangement or coaptation regions comprising opposed inclined flaps connected to parallel lips. The claims specify cracking pressure ranges of 12 to 24 inches H2O or 121 to 160 inches H2O across different structural embodiments. The background problem addressed is not explicitly described in the provided patent content.

Claims Coverage

The four independent claims cover implantable bronchial flow control devices comprising valves that block inspiratory airflow, remain closed during normal breathing, and open during expiratory airflow at coughing pressures across four inventive features.

Two-lip valve with a 12–24 inches H2O cracking pressure

Independent claim 1 covers a valve element comprising first and second lips configured to block airflow in the inspiratory direction and permit airflow in the expiratory direction, remaining closed with no airflow and during normal breathing pressures, and opening during expiratory airflow at coughing pressures with a cracking pressure of 12–24 inches H2O.

Coaptation regions with inclined flaps and parallel lips at 12–24 inches H2O cracking pressure

Independent claim 8 covers coaptation regions comprising two opposed inclined flaps and two parallel lips connected to the flaps, configured to block inspiratory airflow, remain closed with no airflow and during normal breathing pressures, and open during expiratory airflow at coughing pressures with a cracking pressure of 12–24 inches H2O.

Two-lip valve with a 121–160 inches H2O cracking pressure

Independent claim 15 covers a valve element comprising first and second lips configured to block airflow in the inspiratory direction and permit airflow in the expiratory direction, remaining closed with no airflow and during normal breathing pressures, and opening during expiratory airflow at coughing pressures with a cracking pressure of 121–160 inches H2O.

Coaptation regions with inclined flaps and parallel lips at 121–160 inches H2O cracking pressure

Independent claim 19 covers coaptation regions comprising two opposed inclined flaps and two parallel lips connected to the flaps, configured to block inspiratory airflow, remain closed with no airflow and during normal breathing pressures, and open during expiratory airflow at coughing pressures with a cracking pressure of 121–160 inches H2O.

The independent claims cover two structural configurations—a two-lip valve element and coaptation regions comprising inclined flaps and parallel lips—each claimed with either a 12–24 or a 121–160 inches H2O cracking pressure range.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Implantation in a bronchial passageway to isolate targeted lung regions and regulate airflow to promote regional lung collapse.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.